Skip to main content
. 2021 Oct 12;11:20232. doi: 10.1038/s41598-021-99271-3

Table 3.

Surgical staging of 124 patients with locally advanced stage IIIA/B NSCLC after neoadjuvant chemotherapy or chemoradiation.

No residual disease IA IB IIA IIB IIIA IIIB IV Total

Total

(p value)

44 (35.5%)

(p = 0.001)

24 (19.4%)

(p = 0.423)

17 (13.7%)

(p = 0.229)

8 (6.5%)

(p = 0.260)

10 (8.1%)

(p = 1.000)

18 (14.5%)

(p = 0.001)

1 (0.8%)

(p = 0.999)

2 (1.6%)

(p = 0.999)

124